Literature DB >> 9614076

AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes.

M Foretz1, D Carling, C Guichard, P Ferré, F Foufelle.   

Abstract

Although it is now clearly established that a number of genes involved in glucose and lipid metabolism are up-regulated by high glucose concentrations in both liver and adipose tissue, the signaling pathway arising from glucose to the transcriptional machinery is still poorly understood. We have analyzed the regulation of fatty acid synthase gene expression by glucose in cultured rat hepatocytes. Glucose (25 mM) induces an activation of the transcription of the fatty acid synthase gene, and this effect is markedly reduced by incubation of the cells with okadaic acid, an inhibitor of protein phosphatases 1 and 2A. A similar reduction in glucose-activated fatty acid synthase gene expression is obtained by incubation with 5-amino-imidazolecarboxamide riboside, a cell-permeable activator of the AMP-activated protein kinase. Taken together, these results indicate that the glucose-induced expression of the fatty acid synthase gene involves a phosphorylation/dephosphorylation mechanism and suggest that the AMP-activated protein kinase plays an important role in this process. This is the first evidence that implicates the AMP-activated protein kinase in the regulation of gene expression. AMP-activated protein kinase is the mammalian analog of SNF1, a kinase involved in yeast in the transcriptional regulation of genes by glucose.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9614076     DOI: 10.1074/jbc.273.24.14767

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

Review 1.  AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function.

Authors:  D Grahame Hardie
Journal:  Genes Dev       Date:  2011-09-15       Impact factor: 11.361

Review 2.  New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c.

Authors:  Fabienne Foufelle; Pascal Ferré
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

3.  Active Snf1 protein kinase inhibits expression of the Saccharomyces cerevisiae HXT1 glucose transporter gene.

Authors:  Lidia Tomás-Cobos; Pascual Sanz
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

4.  Effect of LKB1 deficiency on mitochondrial content, fibre type and muscle performance in the mouse diaphragm.

Authors:  J D Brown; C R Hancock; A D Mongillo; J Benjamin Barton; R A DiGiovanni; A C Parcell; W W Winder; D M Thomson
Journal:  Acta Physiol (Oxf)       Date:  2011-01-19       Impact factor: 6.311

5.  Naturally occurring R225W mutation of the gene encoding AMP-activated protein kinase (AMPK)gamma(3) results in increased oxidative capacity and glucose uptake in human primary myotubes.

Authors:  S A Crawford; S R Costford; C Aguer; S C Thomas; R A deKemp; J N DaSilva; D Lafontaine; M Kendall; R Dent; R S B Beanlands; R McPherson; M-E Harper
Journal:  Diabetologia       Date:  2010-05-15       Impact factor: 10.122

6.  5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.

Authors:  Clinton M Hasenour; D Emerson Ridley; Curtis C Hughey; Freyja D James; E Patrick Donahue; Jane Shearer; Benoit Viollet; Marc Foretz; David H Wasserman
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

7.  Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology.

Authors:  Shuji Ogino; Meir Stampfer
Journal:  J Natl Cancer Inst       Date:  2010-03-05       Impact factor: 13.506

Review 8.  Lipid-induced insulin resistance in the liver: role of exercise.

Authors:  Christos S Katsanos
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

9.  Role of AMP-activated protein kinase in mechanism of metformin action.

Authors:  G Zhou; R Myers; Y Li; Y Chen; X Shen; J Fenyk-Melody; M Wu; J Ventre; T Doebber; N Fujii; N Musi; M F Hirshman; L J Goodyear; D E Moller
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

10.  Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations.

Authors:  Cordula M Wolf; Michael Arad; Ferhaan Ahmad; Atsushi Sanbe; Scott A Bernstein; Okan Toka; Tetsuo Konno; Gregory Morley; Jeffrey Robbins; J G Seidman; Christine E Seidman; Charles I Berul
Journal:  Circulation       Date:  2007-12-24       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.